Outsourced Pharma Capacity Update Videos - Fill/Finish

1. Resilience Capabilities Update July 2026: Fill/Finish 8/7/2026

   Learn how expanding capacity, automation, and flexible manufacturing technologies are helping biologics manufacturers meet evolving market and quality demands.

2. Thermo Fisher Scientific Capabilities Update July 2026: Fill/Finish 8/6/2026

   When working with high-value biologics, ADCs, and personalized medicines, material utilization decisions made before GMP manufacturing can make or break your program yield. Learn how early choices matter.

3. Pace Life Sciences Capabilities Update July 2026: Fill/ Finish 8/3/2026

   Flexible CDMO networks separate early formulation from clinical fill-and-finish, using manual and automated isolators to protect delicate modalities while accelerating trial timelines.

4. Ardena Capabilities Update July 2026: Fill/Finish 8/3/2026

   Grade A isolators and sterilization protect delicate biologics. Precision container closures maintain integrity down to -80°C, ensuring full compliance across clinical fill-and-finish workflows.

5. Simtra Capabilities Update April 2026: Fill/Finish 4/28/2026

   A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.

6. Upperton Capabilities Update April 2026: Fill/Finish 4/28/2026

   An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.

7. Kindeva Capabilities Update April 2026: Fill/ Finish 4/28/2026

   An overview of sterile fill‑finish capabilities showcasing automated aseptic technologies, scalable capacity, and collaborative approaches for efficient, reliable injectable supply.

8. Grand River Aseptic Manufacturing Capabilities Update April 2026: Fill/Finish 4/28/2026

   A sterile injectable CDMO providing fill‑and‑finish services across vials, syringes, and cartridges, supported by isolator-based filling lines and biologics-ready scale.

9. August BioServices Capabilities Update April 2026: Fill/Finish 4/28/2026

   A U.S.-based sterile injectable CDMO delivering scalable small and large molecule manufacturing, supported by advanced aseptic technologies, integrated quality systems, and commercial-ready capabilities.

10. ROIS Capabilities Update March 2026: Fill/Finish 3/10/2026

    End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.